BRUSSELS (Reuters) – The European Medicines Agency will hold a news conference at 1300 GMT on Tuesday, a spokesman for the EU’s executive arm said.
EMA is conducting an investigation into the safety of AstraZeneca’s COVID-19 shot after Germany, France, Italy and other EU countries suspended the use of the vaccine over isolated cases of bleeding, blood clots and low platelet counts.
Source: Read Full Article